Caladrius biosciences, inc. (CLBS)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current Assets
Cash and cash equivalents

20,745

14,032

12,674

11,754

14,424

10,299

14,374

22,725

21,600

29,163

15,077

23,044

11,997

7,076

18,606

17,699

25,426

20,318

24,042

36,211

19,131

19,174

32,141

32,865

41,359

46,133

16,946

14,722

9,253

13,737

5,390

2,112

21,771

3,935

11,713

4,850

8,469

Restricted cash

-

-

-

-

-

-

0

0

5,007

5,005

5,002

5,000

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

0

11,125

16,487

21,901

23,946

32,754

31,775

27,597

26,983

25,917

44,371

36,324

-

0

-

-

-

-

5,349

3,011

0

7,080

665

920

-

0

-

-

-

-

-

-

-

-

-

-

-

Short term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,427

4,897

-

Accounts receivable, net of allowances of $0 at March 31, 2018 and December 31, 2017, respectively

-

-

-

-

-

-

-

-

144

-

401

335

3,168

138

4,274

2,892

2,612

2,566

2,299

1,297

1,968

3,111

2,088

2,510

1,887

1,860

1,394

701

886

1,053

1,794

1,256

10,438

1,010

8,944

7,351

28

Deferred costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,911

-

-

-

2,566

-

-

-

1,270

-

-

-

-

-

-

-

-

-

-

-

Deferred costs

-

-

-

-

-

-

-

-

-

-

-

-

3,538

-

4,315

5,149

3,986

-

3,348

2,973

3,621

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,142

2,033

1,475

-

529

31

1,541

1,113

448

1,161

17,982

647

20,582

25,008

0

Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

628

-

621

-

-

Prepaid and other current assets

461

815

1,083

1,163

1,276

1,053

1,102

1,228

792

1,312

920

5,706

3,228

1,900

2,767

3,512

3,592

3,476

3,441

3,980

4,296

4,349

4,376

2,525

1,833

1,561

1,466

993

995

803

3,228

882

2,154

649

1,808

1,252

322

Assets related to discontinued operations

-

-

-

-

-

-

-

-

-

-

0

0

-

15,533

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37,024

46,838

-

32,367

-

-

38,062

Total current assets

21,206

25,972

30,244

34,818

39,646

44,106

47,252

51,551

54,529

61,397

65,773

70,412

21,933

24,648

29,964

29,253

35,617

29,272

38,481

47,474

29,018

36,281

41,413

40,854

46,556

50,826

20,336

16,449

12,676

16,707

47,886

52,252

52,975

38,610

45,098

43,361

46,882

Property and equipment, net

87

100

115

130

148

165

182

98

178

257

364

432

16,760

705

17,123

17,039

16,923

17,064

17,095

16,811

15,852

15,960

15,686

15,639

13,790

12,844

11,331

10,873

10,794

11,153

11,067

11,301

47,327

11,616

49,571

50,285

435

Deferred Income Tax Assets, Net

-

-

-

-

-

-

-

-

575

575

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Land use rights, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,875

-

4,870

4,850

-

Goodwill

-

-

-

-

-

-

-

-

-

-

-

-

7,013

-

7,013

7,013

7,013

7,013

25,209

25,209

25,209

25,209

25,209

26,079

11,117

11,117

11,117

11,117

11,117

11,117

11,117

11,117

19,666

11,117

32,586

37,216

0

Intangible assets, net

-

-

-

-

-

-

-

-

-

-

-

-

2,165

-

2,450

2,592

2,735

2,877

37,706

37,857

47,409

47,560

47,711

49,363

13,724

13,875

14,026

14,178

14,329

14,480

14,632

14,783

36,273

15,086

30,461

31,191

563

Other assets

847

1,081

1,312

1,402

1,494

309

418

442

1,434

1,722

1,417

1,402

655

1,582

726

812

894

976

1,209

1,271

1,325

1,263

1,317

1,459

1,204

1,151

973

990

979

947

932

3,507

6,164

3,326

5,625

3,427

2,798

Assets related to discontinued operations

-

-

-

-

-

-

-

-

-

-

0

0

-

26,577

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Assets related to discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43,169

45,063

-

75,570

-

-

92,344

Total assets

22,140

27,153

31,671

36,350

41,288

44,580

47,853

52,092

56,716

63,376

67,555

72,247

48,528

53,514

57,278

56,712

63,184

57,205

119,702

128,624

118,813

126,275

131,338

133,395

86,393

89,816

57,786

53,609

49,897

54,406

128,806

138,026

167,284

155,327

168,214

170,332

143,024

LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Liabilities
Accounts payable

64

1,490

844

559

553

762

447

505

866

1,343

879

1,114

3,578

2,226

3,245

2,903

3,984

4,107

2,467

2,266

2,928

5,661

4,400

5,481

3,296

3,354

3,091

2,410

2,191

2,555

2,570

2,171

19,395

2,287

9,896

9,267

595

Accrued Liabilities, Current

4,556

4,486

5,135

5,153

4,548

4,857

4,444

5,299

6,998

7,812

10,135

12,408

5,061

2,659

6,372

6,202

6,322

6,198

8,011

7,178

5,723

4,322

2,818

2,587

2,381

4,018

2,231

1,988

1,683

2,284

1,385

2,108

3,430

1,090

5,863

4,899

720

Liabilities of Business Transferred under Contractual Arrangement, Current

-

-

-

-

-

-

-

-

-

-

-

-

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt, current

-

-

-

-

-

-

-

-

-

-

0

0

3,193

3,126

2,319

5,007

1,158

4,171

2,751

1,361

2,242

1,109

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Bank loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,810

-

7,810

7,735

-

Notes payable, current

-

-

-

-

-

-

0

23

92

159

359

578

1,014

563

745

1,012

1,358

1,192

1,012

882

1,061

816

995

794

836

381

402

278

143

202

135

154

254

148

3,766

11,056

116

Due to PCT

-

-

-

-

-

-

-

-

-

-

0

450

-

1,681

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Mortgages payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

218

216

213

3,288

3,345

3,395

3,438

3,493

3,541

3,582

3,635

187

185

0

Derivative Liabilities, Current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

23

23

-

-

-

0

-

-

-

-

-

-

-

Income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,073

-

589

672

-

Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

655

-

338

780

-

Unearned revenues, current

-

-

-

-

-

-

-

-

-

-

-

-

5,364

-

5,869

7,231

5,638

5,345

5,498

4,643

5,505

4,334

3,639

2,830

2,033

1,816

1,021

362

1,815

1,468

778

1,631

2,934

1,121

3,066

4,169

59

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,728

-

-

-

-

-

-

Liabilities related to discontinued operations

-

-

-

-

-

-

-

-

-

-

0

0

-

10,925

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39,343

38,407

-

28,165

-

-

31,397

Total current liabilities

4,620

5,976

5,979

5,712

5,101

5,619

4,892

5,828

7,957

9,314

11,374

14,551

23,212

21,182

18,553

22,356

18,463

21,015

19,739

16,331

17,462

16,244

11,854

11,912

8,786

9,806

10,036

8,384

9,228

9,949

50,435

48,015

47,135

36,446

31,517

38,766

32,890

Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

1,120

-

1,079

1,032

986

932

14,566

14,519

18,222

18,176

18,422

18,983

4,426

4,379

4,091

4,046

3,599

3,599

3,774

3,774

9,171

3,774

5,655

9,498

0

Notes payable

-

-

-

-

-

-

-

-

-

-

0

23

215

159

224

321

450

583

814

1,254

662

825

956

1,015

870

531

348

220

149

171

48

57

50

0

-

-

-

Deferred rent liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

19

-

Unearned revenues, long-term

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

143

156

156

169

180

250

282

Unearned revenues - long-term

-

-

-

-

-

-

-

-

-

-

-

-

4,447

-

4,329

3,812

2,776

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term Debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,023

-

-

-

0

-

-

-

-

-

-

-

Mortgages payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,000

2,912

2,967

-

-

-

-

-

-

-

-

-

3,487

3,534

-

Long term debt

-

-

-

-

-

-

-

-

-

-

0

0

1,701

2,524

3,331

3,643

7,492

10,828

12,248

13,638

12,757

13,890

15,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,260

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,880

13,460

18,810

-

22,430

20,640

9,640

9,450

-

-

-

-

-

-

-

-

-

-

-

Derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

114

32

90

101

427

362

387

474

910

2,276

2,571

Acquisition-related contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,550

7,550

7,550

7,550

3,130

3,130

3,130

3,130

-

-

0

Other long-term liabilities

536

624

710

1,016

1,729

1,507

2,152

2,797

3,443

3,873

3,200

3,636

407

389

370

508

432

562

3,457

3,467

930

804

616

635

635

598

511

383

275

214

139

70

-

0

-

-

-

Liabilities related to discontinued operations

-

-

-

-

-

-

-

-

-

-

0

0

-

5,791

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,279

27,026

-

26,388

-

-

14,260

Amount due related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,293

-

20,534

20,009

-

Total liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33,921

-

-

-

68,201

-

-

27,326

27,789

12,615

12,232

11,664

21,586

21,943

34,577

34,189

33,937

30,778

35,589

17,114

Total liabilities

5,156

6,600

6,689

6,728

6,830

7,126

7,044

8,625

11,400

13,187

14,574

18,211

31,104

30,047

27,889

31,676

30,601

-

64,706

62,671

68,845

-

69,279

56,098

-

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and Contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

Redeemable Securities - Non-Controlling Interests

-

-

-

-

-

-

-

-

-

-

-

-

-

19,400

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Redeemable Securities - Non-Controlling Interests

-

-

-

-

-

-

-

-

-

-

0

0

19,400

-

19,400

19,400

19,400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Temporary Equity, Carrying Amount, Total

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,182

-

5,475

5,901

6,532

Stockholders' Equity
Convertible Redeemable Series E Preferred Stock; 10,582,011 shares designated, liquidation value $1.00 per share; issued and outstanding 0 shares and 6,662,748 shares at December 31, 2012 and 2011, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,721

3,574

4,182

4,811

5,475

5,901

6,532

Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at March 31, 2020 and December 31, 2019, respectively

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value, authorized 500,000,000 shares; issued and outstanding, 10,638,771 and 10,528,689 shares at March 31, 2020 and December 31, 2019, respectively

11

11

10

10

10

10

9

9

9

9

9

8

8

8

8

5

59

5

55

55

39

36

35

34

28

27

21

19

170

16

155

137

129

109

100

82

63

Additional paid-in capital

439,330

438,911

438,388

438,133

437,850

436,433

436,227

435,337

433,137

433,044

433,006

430,606

414,056

410,372

410,276

398,699

398,423

396,547

395,014

394,589

361,503

350,428

343,308

341,369

310,377

299,594

260,212

248,877

236,113

231,218

225,528

215,184

211,635

200,858

192,575

174,599

141,137

Treasury stock, at cost; 11,080 shares at March 31, 2020 and December 31, 2019

708

708

708

708

708

708

707

707

707

708

707

707

707

707

707

707

707

707

705

705

705

705

705

705

705

705

694

665

665

665

-

-

-

0

-

-

-

Accumulated deficit

-421,390

-417,400

-412,444

-407,546

-402,406

-397,977

-394,419

-390,869

-386,792

-381,810

-378,947

-375,429

-414,148

-404,788

-398,830

-391,948

-384,113

-372,132

-338,935

-327,559

-310,433

-291,246

-279,634

-262,660

-250,055

-236,373

-223,839

-214,768

-206,192

-197,392

-181,622

-173,144

-152,550

-143,094

-124,116

-116,456

-95,320

Accumulated other comprehensive income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

1

0

1

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Accumulated other comprehensive income

0

2

2

0

-18

-32

-28

-31

-58

-28

-28

-57

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,148

4,174

4,156

4,152

5,001

4,289

2,779

Total Caladrius Biosciences, Inc. stockholders' equity

17,243

20,816

25,248

29,889

34,728

37,726

41,081

43,739

45,588

50,507

53,332

54,420

-790

4,883

10,745

6,050

13,661

23,713

55,429

66,381

50,403

58,514

63,003

78,039

59,644

62,542

35,699

33,463

29,424

33,177

48,209

46,352

63,371

62,025

73,561

62,514

48,659

Noncontrolling interests

-259

-263

-266

-267

-270

-272

-272

-273

-272

-318

-352

-384

-1,184

-817

-756

-413

-478

-429

-432

-428

-435

-441

-944

-741

-577

-516

-565

-471

-420

-356

5,496

5,506

18,406

18,106

26,881

27,560

37,827

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest

16,984

20,553

24,982

29,622

34,458

37,454

40,809

43,466

45,315

50,189

52,980

54,036

-1,975

4,066

9,989

5,636

13,182

23,283

54,996

65,953

49,968

58,073

62,058

77,297

59,066

62,026

35,134

32,992

29,004

32,820

53,706

51,858

81,777

80,132

100,442

90,074

86,487

Liabilities and Equity, Total

22,140

27,153

31,671

36,350

41,288

44,580

47,853

52,092

56,716

63,376

67,555

72,247

48,528

53,514

57,278

56,712

63,184

57,205

119,702

128,624

118,813

126,275

131,338

133,395

86,393

89,816

57,786

53,609

49,897

54,406

128,806

138,026

167,284

155,327

168,214

170,332

143,024